DK171340B1 - Substituerede 2-((4-fluoralkoxypyrid-2-yl)metyltio eller metylsulfinyl)benzimidazoler, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende en sådan forbindelse - Google Patents
Substituerede 2-((4-fluoralkoxypyrid-2-yl)metyltio eller metylsulfinyl)benzimidazoler, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende en sådan forbindelse Download PDFInfo
- Publication number
- DK171340B1 DK171340B1 DK356485A DK356485A DK171340B1 DK 171340 B1 DK171340 B1 DK 171340B1 DK 356485 A DK356485 A DK 356485A DK 356485 A DK356485 A DK 356485A DK 171340 B1 DK171340 B1 DK 171340B1
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- methyl
- compounds
- compound according
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17106984 | 1984-08-16 | ||
JP59171069A JPS6150978A (ja) | 1984-08-16 | 1984-08-16 | ピリジン誘導体およびその製造法 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK356485D0 DK356485D0 (da) | 1985-08-06 |
DK356485A DK356485A (da) | 1986-02-17 |
DK171340B1 true DK171340B1 (da) | 1996-09-16 |
Family
ID=15916456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK356485A DK171340B1 (da) | 1984-08-16 | 1985-08-06 | Substituerede 2-((4-fluoralkoxypyrid-2-yl)metyltio eller metylsulfinyl)benzimidazoler, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende en sådan forbindelse |
Country Status (23)
Country | Link |
---|---|
US (2) | US4628098A (fr) |
EP (1) | EP0174726B1 (fr) |
JP (1) | JPS6150978A (fr) |
KR (1) | KR920002128B1 (fr) |
AU (1) | AU570130B2 (fr) |
BG (1) | BG60415B2 (fr) |
CA (1) | CA1255314A (fr) |
DE (3) | DE19975017I2 (fr) |
DK (1) | DK171340B1 (fr) |
ES (1) | ES8607288A1 (fr) |
GE (1) | GEP19960313B (fr) |
GR (1) | GR851981B (fr) |
HK (1) | HK4792A (fr) |
HU (1) | HU195210B (fr) |
IE (1) | IE58363B1 (fr) |
MX (1) | MX9203043A (fr) |
NL (1) | NL930109I2 (fr) |
NO (2) | NO163131C (fr) |
PH (1) | PH20946A (fr) |
SG (1) | SG103291G (fr) |
SU (1) | SU1507211A3 (fr) |
UA (1) | UA7140A1 (fr) |
ZA (1) | ZA856117B (fr) |
Families Citing this family (237)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0174717B1 (fr) | 1984-07-06 | 1992-01-22 | FISONS plc | Benzimidazoles, et leur préparation, formulation et application comme inhibiteur de sécrétion d'acide gastrique |
US6749864B2 (en) * | 1986-02-13 | 2004-06-15 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
US5433959A (en) | 1986-02-13 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
CA1327010C (fr) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production |
CA1276017C (fr) * | 1986-02-13 | 1990-11-06 | Takeda Chemical Industries, Ltd. | Derives de sulfenamide, et leur production |
DK171989B1 (da) * | 1987-08-04 | 1997-09-08 | Takeda Chemical Industries Ltd | Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler |
WO1989011479A1 (fr) * | 1988-05-25 | 1989-11-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Nouveaux composes fluores d'alkoxyde |
JP2536173B2 (ja) * | 1988-08-18 | 1996-09-18 | 武田薬品工業株式会社 | 注射剤 |
US5223515A (en) * | 1988-08-18 | 1993-06-29 | Takeda Chemical Industries, Ltd. | Injectable solution containing a pyridyl methylsulfinylbenzimidazole |
AT391693B (de) * | 1988-11-15 | 1990-11-12 | Cl Pharma | Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer |
SE8804629D0 (sv) | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
EG19302A (en) * | 1988-12-22 | 1994-11-30 | Haessle Ab | Compound with gastric acid inhibitory effect and process for its preparation |
SE8804628D0 (sv) | 1988-12-22 | 1988-12-22 | Ab Haessle | New compounds |
ES2066120T3 (es) * | 1989-02-10 | 1995-03-01 | Takeda Chemical Industries Ltd | Uso de derivados de bencimidazol como agentes antibacterianos. |
US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
US5049674A (en) * | 1989-12-20 | 1991-09-17 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
US5274099A (en) * | 1989-12-20 | 1993-12-28 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
DE69132082T2 (de) | 1990-10-17 | 2000-08-31 | Takeda Chemical Industries Ltd | Pyridin-Derivate, Verfahren zu deren Herstellung und Anwendung |
TW209174B (fr) | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
NZ244301A (en) * | 1991-09-20 | 1994-08-26 | Merck & Co Inc | Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds |
ES2036948B1 (es) * | 1991-11-21 | 1994-09-01 | Genesis Para La Investigacion | Procedimiento de obtencion de compuestos derivados de piridina. |
KR950702416A (ko) * | 1992-07-08 | 1995-07-29 | 제임스 클리프튼 보올딩 | 돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸(Benzimidazoles for alloviating stomach ulcers in swine) |
US5589491A (en) * | 1992-07-28 | 1996-12-31 | Astra Aktiebolag | Injection and injection kit containing omeprazole and its analogs |
EP0683776B1 (fr) * | 1993-02-17 | 1999-04-07 | Byk Gulden Lomberg Chemische Fabrik GmbH | Heteroarylalkylthiopyridines substituees pour la lutte contre les bacteries helicobacter |
ES2060541B1 (es) * | 1993-02-26 | 1995-11-16 | Vinas Lab | Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo. |
ES2063705B1 (es) * | 1993-06-14 | 1995-07-16 | S A L V A T Lab Sa | Intermedio para la sintesis de lansoprazol y su procedimiento de obtencion. |
TW280770B (fr) * | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
US5374730A (en) * | 1993-11-04 | 1994-12-20 | Torcan Chemical Ltd. | Preparation of omeprazole and lansoprazole |
US5502195A (en) * | 1993-11-04 | 1996-03-26 | Slemon; Clarke | Sulfoxide-carboxylate intermediates of omeprazole and lansoprazole |
CN1048980C (zh) * | 1994-03-29 | 2000-02-02 | 广东汕头鮀滨化学药业总公司 | 一种新的吡啶衍生物及其制备方法和应用 |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
HRP960232A2 (en) * | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
ES2236628T3 (es) * | 1995-09-21 | 2005-07-16 | Pharma Pass Ii Llc | Composicion farmaceutica que contiene un omeprazol labil de acido, y procedimiento para su preparacion. |
SE521100C2 (sv) * | 1995-12-15 | 2003-09-30 | Astra Ab | Förfarande för framställning av en bensimidazolförening |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US6380222B2 (en) | 1996-10-11 | 2002-04-30 | Astrazeneca Ab | Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps |
TW385306B (en) * | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
US6051570A (en) * | 1997-05-30 | 2000-04-18 | Dr. Reddy's Research Foundation | Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
ES2232015T3 (es) | 1997-07-25 | 2005-05-16 | Altana Pharma Ag | Inhibidor de las bombas de protones en combinacion terapeutica con sustancias antibacterianas. |
SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
DK1736144T3 (en) | 1998-05-18 | 2015-12-07 | Takeda Pharmaceutical | Orally disintegrating tablets. |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
WO2000000474A1 (fr) * | 1998-06-26 | 2000-01-06 | Russinsky Limited | Blocs constitutifs de pyrimidine utilises comme intermediaires dans la synthese de composes pharmaceutiquement actifs |
SI20019A (sl) * | 1998-07-13 | 2000-02-29 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola |
CA2337886C (fr) * | 1998-07-22 | 2008-04-08 | Sepracor Inc. | Compositions pharmaceutiques contenant de l'hydroxylansoprazole et utilisations de ces dernieres |
NZ510180A (en) * | 1998-08-10 | 2002-11-26 | Univ California | Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors |
US6093734A (en) * | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
ES2262335T3 (es) | 1998-08-12 | 2006-11-16 | Altana Pharma Ag | Forma de administracion oral para piridin-2-ilmetilsulfinil-1h-bencimidazoles. |
DE19843413C1 (de) * | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
JP3926936B2 (ja) | 1998-11-16 | 2007-06-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホキシド誘導体・アセトン錯体およびその製造法 |
US20040224989A1 (en) * | 1999-01-29 | 2004-11-11 | Barberich Timothy J. | S-lansoprazole compositions and methods |
US6852739B1 (en) * | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
TWI243672B (en) | 1999-06-01 | 2005-11-21 | Astrazeneca Ab | New use of compounds as antibacterial agents |
YU86001A (sh) | 1999-06-07 | 2004-07-15 | Altana Pharma Ag. | Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini |
TWI275587B (en) | 1999-06-17 | 2007-03-11 | Takeda Chemical Industries Ltd | A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
EP1191025B1 (fr) * | 1999-06-30 | 2005-06-22 | Takeda Pharmaceutical Company Limited | Cristaux de lansoprazole |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6228400B1 (en) | 1999-09-28 | 2001-05-08 | Carlsbad Technology, Inc. | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
KR100359256B1 (ko) * | 1999-10-06 | 2002-11-04 | 한미약품공업 주식회사 | 란소프라졸의 개선된 제조방법 |
SE9903831D0 (sv) * | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20060034937A1 (en) * | 1999-11-23 | 2006-02-16 | Mahesh Patel | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
ES2171116B1 (es) * | 2000-04-14 | 2003-08-01 | Esteve Quimica Sa | Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol. |
ES2511774T3 (es) * | 2000-05-15 | 2014-10-23 | Takeda Pharmaceutical Company Limited | Formas cristalinas de (R)-lansoprazol |
CA2417311C (fr) | 2000-08-04 | 2012-07-10 | Takeda Chemical Industries, Ltd. | Sels cristallins de metal alcalin et de lansoprazole et methode de production et utilisation connexes |
US6544556B1 (en) | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
AU2001296908A1 (en) * | 2000-09-29 | 2002-04-08 | Geneva Pharmaceuticals, Inc. | Proton pump inhibitor formulation |
TWI290922B (en) | 2000-12-01 | 2007-12-11 | Takeda Chemical Industries Ltd | Production method of crystals |
WO2002045692A1 (fr) | 2000-12-07 | 2002-06-13 | Altana Pharma Ag | Preparation pharmaceutique sous forme de suspension contenant un ingredient actif labile en milieu acide |
WO2002045694A1 (fr) | 2000-12-07 | 2002-06-13 | Altana Pharma Ag | Comprime a desintegration rapide comprenant un ingredient actif acido-labile |
CA2430816C (fr) | 2000-12-07 | 2012-05-15 | Altana Pharma Ag | Preparation pharmaceutique sous forme d'une pate contenant un ingredient actif labile en milieu acide |
KR100430575B1 (ko) * | 2001-02-21 | 2004-05-10 | 주식회사 씨트리 | 란소프라졸 및 그 중간체의 제조방법 |
US6645946B1 (en) | 2001-03-27 | 2003-11-11 | Pro-Pharmaceuticals, Inc. | Delivery of a therapeutic agent in a formulation for reduced toxicity |
SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
JP4020076B2 (ja) | 2001-09-18 | 2007-12-12 | ゼリア新薬工業株式会社 | ベンズイミダゾール誘導体 |
US20040248941A1 (en) * | 2001-09-25 | 2004-12-09 | Keiji Kamiyama | Benzimidazone compound, process for producing the same, and use thereof |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
PT1459737E (pt) | 2001-10-17 | 2012-11-26 | Takeda Pharmaceutical | Grânulos contendo um composto químico instável em meio ácido em concentração elevada |
SE0104295D0 (sv) * | 2001-12-18 | 2001-12-18 | Astrazeneca Ab | New process |
US7906145B2 (en) | 2002-04-09 | 2011-03-15 | Flamel Technologies | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
AU2003246791A1 (en) | 2002-04-09 | 2003-10-20 | Flamel Technologies | Oral suspension of amoxicillin capsules |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
KR100873419B1 (ko) * | 2002-06-18 | 2008-12-11 | 페어차일드코리아반도체 주식회사 | 높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자 |
JP4463103B2 (ja) * | 2002-07-19 | 2010-05-12 | ウィンストン・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニー | ベンズイミダゾール誘導体およびプロトンポンプ阻害剤のプロドラッグとしてのその使用 |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
US7211590B2 (en) * | 2002-08-01 | 2007-05-01 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
ATE375338T1 (de) * | 2002-08-21 | 2007-10-15 | Teva Pharma | Verfahren zur aufreinigung von lanzoprazol |
EP1545548B1 (fr) | 2002-08-30 | 2010-06-30 | Nycomed GmbH | Utilisation de la combinaison de ciclesonide et d'antihistaminiques pour le traitement de la rhinite allergique |
EP2596792A1 (fr) * | 2002-10-16 | 2013-05-29 | Takeda Pharmaceutical Company Limited | Préparations solides stables |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
EP1743893A1 (fr) | 2002-11-18 | 2007-01-17 | Teva Pharmaceutical Industries Ltd. | Lansoprazole stable contenant plus de 500 parties par million, jusqu'à environ 3000 parties par million d'eau et plus de 200 parties par million, jusqu'à environ 5000 parties par million d'alcool |
DE03789888T1 (de) * | 2002-11-18 | 2005-08-18 | Teva Pharmaceutical Industries Ltd. | Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol |
DE10254167A1 (de) | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen |
CA2507807C (fr) | 2002-12-06 | 2013-10-22 | Altana Pharma Ag | Procede de preparation de composes actifs optiquement purs inhibiteurs de la pompe a protons |
SI1575941T1 (sl) | 2002-12-06 | 2012-08-31 | Nycomed Gmbh | Postopek za pripravo (S)-pantoprazola |
US7507829B2 (en) * | 2002-12-19 | 2009-03-24 | Teva Pharmaceuticals Industries, Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US7678816B2 (en) * | 2003-02-05 | 2010-03-16 | Teva Pharmaceutical Industries Ltd. | Method of stabilizing lansoprazole |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
EP1601667A2 (fr) * | 2003-03-12 | 2005-12-07 | Teva Pharmaceutical Industries Limited | Formes solides cristallines et amorphes de pantoprazole et procedes de preparation de ces formes |
WO2004080439A1 (fr) * | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | Composition de medicament comportant un principe actif adhere en concentration elevee a un noyau spherique |
EP1611901B1 (fr) * | 2003-03-13 | 2013-07-10 | Eisai R&D Management Co., Ltd. | Medicament destiné à prevenir ou à traiter les grincements de dents |
US20050031696A1 (en) * | 2003-04-22 | 2005-02-10 | Dr. Reddy's Laboratories Limited | Oral pharmaceutical formulations of acid-labile active ingredients and process for making same |
PE20050150A1 (es) | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
CL2004000983A1 (es) | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
EP1615913A2 (fr) * | 2003-06-10 | 2006-01-18 | Teva Pharmaceutical Industries Limited | Procede de preparation de benzimidazoles 2- (pyridinyl)methyl]sulfinyle substitues et nouveau derives chlorures de pantoprazole |
EP2112920B1 (fr) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif |
KR20060041224A (ko) * | 2003-07-15 | 2006-05-11 | 알러간, 인코포레이티드 | 양성자 펌프 억제제의 이성질체적으로 순수한 프로드러그를제조하는 방법 |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050232992A1 (en) * | 2003-09-03 | 2005-10-20 | Agi Therapeutics Limited | Proton pump inhibitor formulations, and methods of preparing and using such formulations |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
US20060241037A1 (en) * | 2003-10-03 | 2006-10-26 | Allergan Inc. | Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs |
EP1718303A4 (fr) * | 2004-02-10 | 2010-09-01 | Santarus Inc | Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien |
GB0403165D0 (en) * | 2004-02-12 | 2004-03-17 | Ct | Novel uses for proton pump inhibitors |
WO2005082337A2 (fr) * | 2004-02-18 | 2005-09-09 | Allergan, Inc. | Methodes et compositions d'administration de promedicaments d'inhibiteurs de la pompe a protons |
BRPI0507837A (pt) * | 2004-02-18 | 2007-07-10 | Allergan Inc | métodos e composições para a administração intravenosa de compostos relacionados a inibidores de bomba de prótons |
CN1964704A (zh) * | 2004-03-03 | 2007-05-16 | 特瓦制药工业有限公司 | 包含酸不稳定药物的稳定药用组合物 |
CA2561700A1 (fr) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique |
CN1946722A (zh) * | 2004-04-28 | 2007-04-11 | 奥坦纳医药公司 | 二烷氧基咪唑并吡啶衍生物 |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2570916C (fr) | 2004-06-16 | 2013-06-11 | Tap Pharmaceutical Products, Inc. | Forme posologique d'ipp a doses multiples |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
WO2006030936A1 (fr) | 2004-09-13 | 2006-03-23 | Takeda Pharmaceutical Company Limited | Procede et appareil destines a produire un compose oxyde |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
ES2409347T3 (es) | 2004-10-21 | 2013-06-26 | Aptalis Pharmatech, Inc. | Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US20090169566A1 (en) | 2004-11-22 | 2009-07-02 | Anadis Ltd. | Bioactive compositions |
EP1681056A1 (fr) | 2005-01-14 | 2006-07-19 | Krka Tovarna Zdravil, D.D., Novo Mesto | Procédé de préparation du lansoprazole |
EP1852100B1 (fr) | 2005-02-25 | 2018-05-09 | Takeda Pharmaceutical Company Limited | Procédé de fabrication de granulés enrobés du benzimidazole |
KR100771659B1 (ko) | 2005-03-23 | 2007-10-30 | 주식회사 카이로제닉스 | 판토프라졸 및 그 중간체의 제조방법 |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
JPWO2006132217A1 (ja) | 2005-06-07 | 2009-01-08 | 武田薬品工業株式会社 | ベンズイミダゾール化合物の塩の結晶 |
JPWO2006134877A1 (ja) * | 2005-06-13 | 2009-01-08 | 武田薬品工業株式会社 | 注射剤 |
US7601737B2 (en) | 2005-07-26 | 2009-10-13 | Nycomed Gmbh | Isotopically substituted proton pump inhibitors |
US7598273B2 (en) * | 2005-10-06 | 2009-10-06 | Auspex Pharmaceuticals, Inc | Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties |
GB0525710D0 (en) * | 2005-12-17 | 2006-01-25 | Pliva Hrvatska D O O | An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
SG184754A1 (en) | 2005-12-28 | 2012-10-30 | Takeda Pharmaceutical | Controlled release solid preparation |
US8486450B2 (en) | 2005-12-28 | 2013-07-16 | Takeda Pharmaceutical Company Limited | Method of producing solid preparation disintegrating in the oral cavity |
KR101348643B1 (ko) * | 2006-03-10 | 2014-01-08 | 링크 제노믹스 가부시키가이샤 | 항 헬리코박터피로리 작용을 가지는 신규 피리딘 유도체 |
CA2648280C (fr) | 2006-04-03 | 2014-03-11 | Isa Odidi | Dispositif d'administration a liberation commandee comprenant un enrobage organosol |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
JP2009538901A (ja) * | 2006-06-01 | 2009-11-12 | デクセル ファーマ テクノロジーズ エルティーディー. | 複式ユニット製薬的製剤 |
US7863330B2 (en) | 2006-06-14 | 2011-01-04 | Rottapharm S.P.A. | Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders |
RU2467747C2 (ru) | 2006-07-25 | 2012-11-27 | Векта Лтд. | Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi |
WO2008036201A1 (fr) * | 2006-09-19 | 2008-03-27 | Alevium Pharmaceuticals, Inc. | Promédicaments d'inhibiteurs de pompes à protons comprenant le groupe fonctionnel 1h-imidazo[4,5-b] pyridine |
WO2008035189A1 (fr) * | 2006-09-22 | 2008-03-27 | Orchid Chemicals & Pharmaceuticals Limited | Procédé de purification du lansoprazole |
EP2068841B1 (fr) | 2006-10-05 | 2018-09-26 | Santarus, Inc. | Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations |
EP2486910A3 (fr) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Appareil comprenant plusieurs chambres et une tête de distribution |
PL2124884T3 (pl) | 2006-12-22 | 2020-01-31 | Ironwood Pharmaceuticals, Inc. | Metody i kompozycje do leczenia zaburzeń przełyku |
US9486446B2 (en) | 2006-12-28 | 2016-11-08 | Takeda Pharmaceutical Company Limited | Orally disintegrating solid preparation |
WO2008087665A2 (fr) * | 2007-01-18 | 2008-07-24 | Matrix Laboratories Ltd | Procédé de préparation de lansoprazole |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
TW200840574A (en) * | 2007-04-02 | 2008-10-16 | Univ Nat Taiwan | The pharmaceutical component for treating hearing loss disease |
US20100210847A1 (en) * | 2007-07-17 | 2010-08-19 | Ranbaxy Laboratories Limited | Process for the preparation of pantoprazole sodium and pantoprazole sodium sesquihydrate |
WO2009049160A1 (fr) | 2007-10-12 | 2009-04-16 | Takeda Pharmaceuticals North America | Procédés de traitement de troubles gastro-intestinaux indépendants de la prise alimentaire |
NZ585944A (en) * | 2007-12-18 | 2011-11-25 | Watson Pharma Private Ltd | A process for preparation of stable amorphous R-(+)-lansoprazole |
WO2009088857A1 (fr) | 2007-12-31 | 2009-07-16 | Takeda Pharmaceutical Company Limited | Formes solvatées de cristaux de (r) -2- [ [ [3-méthyl-4- (2, 2, 2-trifluoroéthoxy) -2-pyridinyl] méthyl] sulfinyl] -1h-benzimidazole |
US8247440B2 (en) | 2008-02-20 | 2012-08-21 | Curators Of The University Of Missouri | Composition comprising omeprazole, lansoprazole and at least one buffering agent |
US20090227633A1 (en) * | 2008-03-04 | 2009-09-10 | Bassam Damaj | Methods to inhibit tumor cell growth by using proton pump inhibitors |
JP2011513202A (ja) | 2008-03-10 | 2011-04-28 | 武田薬品工業株式会社 | ベンズイミダゾール化合物の結晶 |
US20090263475A1 (en) * | 2008-04-21 | 2009-10-22 | Nagaraju Manne | Dexlansoprazole compositions |
EP2303868A2 (fr) | 2008-05-14 | 2011-04-06 | Watson Pharma Private Limited | Sel stable de r(+)-lansoprazole amine et son procédé de préparation |
BRPI0918492A2 (pt) | 2008-09-09 | 2015-12-01 | Astrazeneca Ab | uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo |
WO2010039885A2 (fr) * | 2008-09-30 | 2010-04-08 | Teva Pharmaceutical Industries Ltd. | Formes cristallines du dexlansoprazole |
US20100093747A1 (en) * | 2008-10-10 | 2010-04-15 | Erica Brook Goodhew | Method of inducing negative chemotaxis |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
WO2010122583A2 (fr) | 2009-04-24 | 2010-10-28 | Rubicon Research Private Limited | Compositions pharmaceutiques orales comprenant des substances labiles en milieu acide |
WO2010134099A1 (fr) | 2009-05-21 | 2010-11-25 | Cadila Healthcare Limited | Procédé de préparation dans un récipient unique d'oméprazole |
WO2011004387A2 (fr) | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | Procédé de préparation de formes polymorphes du dexlansoprazole |
SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
KR101765357B1 (ko) | 2009-12-02 | 2017-08-04 | 아데어 파마수티컬스 에스.알.엘. | 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물 |
WO2011080502A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
WO2011080500A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
WO2011080501A2 (fr) | 2009-12-29 | 2011-07-07 | Orexo Ab | Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique |
AR079862A1 (es) * | 2010-01-08 | 2012-02-22 | Eurand Inc | Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion |
US20110189271A1 (en) * | 2010-02-02 | 2011-08-04 | Vishal Lad | Pharmaceutical formulations of acid-labile drugs |
WO2011138797A2 (fr) | 2010-05-04 | 2011-11-10 | Cadila Healthcare Limited | Composition pharmaceutique de lansoprazole à action différée se désintégrant par la voie buccale |
US20130216617A1 (en) | 2010-06-29 | 2013-08-22 | Cadila Healthcare Limited | Pharmaceutical compositions of (r)-lansoprazole |
WO2012027331A1 (fr) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
CA2819460C (fr) | 2010-12-03 | 2017-08-01 | Takeda Pharmaceutical Company Limited | Comprime a desintegration orale |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
UY33841A (es) | 2010-12-27 | 2012-07-31 | Takeda Pharmaceutical | Comprimido de desintegracion oral |
US9233103B2 (en) | 2011-03-25 | 2016-01-12 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy |
JP5925318B2 (ja) | 2011-11-30 | 2016-05-25 | 武田薬品工業株式会社 | 有核錠 |
EP2601947A1 (fr) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Combinaison à dose fixe pour le traitement de maladies associées à Hélicobacter pylori |
BR112014014558A8 (pt) | 2011-12-16 | 2017-07-04 | Atopix Therapeutics Ltd | composição farmacêutica, uso de um antagonista de crth2 e de um inibidor de bomba de prótons, e, kit para o tratamento de esofagite eosinofílica |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
WO2013108068A1 (fr) | 2012-01-21 | 2013-07-25 | Jubilant Life Sciences Limited | Procédé de préparation de 2-pyridinylméthylsulfinylbenzimidazoles, leurs analogues et énantiomères optiquement actifs |
EP3991719A1 (fr) | 2013-01-15 | 2022-05-04 | Ironwood Pharmaceuticals, Inc. | Forme posologique orale à libération prolongée à rétention gastrique d'un agent séquestrant d'acide biliaire |
CA2913106A1 (fr) | 2013-05-21 | 2014-11-27 | Takeda Pharmaceutical Company Limited | Comprime a delitement oral |
US9457011B2 (en) | 2014-02-25 | 2016-10-04 | Muslim D. Shahid | Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor |
WO2016033556A1 (fr) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide |
WO2016033549A2 (fr) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation |
US20180015118A1 (en) | 2015-02-03 | 2018-01-18 | Ironwood Pharmaceuticals, Inc. | Methods of treating upper gastrointestinal disorders in ppi refractory gerd |
WO2016174664A1 (fr) | 2015-04-29 | 2016-11-03 | Dexcel Pharma Technologies Ltd. | Compositions à désintégration par voie orale |
US10736855B2 (en) | 2016-02-25 | 2020-08-11 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
CN107365300B (zh) * | 2017-07-26 | 2019-08-02 | 桂林华信制药有限公司 | 一种有效去除兰索拉唑粗品中杂质的方法 |
CN114163419A (zh) * | 2021-12-24 | 2022-03-11 | 辰欣药业股份有限公司 | 一种兰索拉唑的制备方法 |
WO2024075017A1 (fr) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition de calcification de valve aortique |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
IL66340A (en) * | 1981-08-13 | 1986-08-31 | Haessle Ab | Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation |
US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
IL71664A (en) * | 1983-05-03 | 1987-11-30 | Byk Gulden Lomberg Chem Fab | Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same |
US4575554A (en) * | 1983-12-05 | 1986-03-11 | The Upjohn Company | Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
GB8417171D0 (en) * | 1984-07-05 | 1984-08-08 | Beecham Group Plc | Compounds |
SE8404065D0 (sv) * | 1984-08-10 | 1984-08-10 | Haessle Ab | Novel biologically active compounds |
-
1984
- 1984-08-16 JP JP59171069A patent/JPS6150978A/ja active Granted
-
1985
- 1985-07-29 US US06/760,568 patent/US4628098A/en not_active Expired - Lifetime
- 1985-07-31 DE DE19975017C patent/DE19975017I2/de active Active
- 1985-07-31 DE DE19975020C patent/DE19975020I2/de active Active
- 1985-07-31 DE DE8585305458T patent/DE3569736D1/de not_active Expired
- 1985-07-31 EP EP19850305458 patent/EP0174726B1/fr not_active Expired
- 1985-08-06 DK DK356485A patent/DK171340B1/da active Protection Beyond IP Right Term
- 1985-08-07 AU AU45895/85A patent/AU570130B2/en not_active Expired
- 1985-08-09 IE IE197685A patent/IE58363B1/en not_active IP Right Cessation
- 1985-08-13 GR GR851981A patent/GR851981B/el unknown
- 1985-08-13 ZA ZA856117A patent/ZA856117B/xx unknown
- 1985-08-13 PH PH32628A patent/PH20946A/en unknown
- 1985-08-14 SU SU3947161A patent/SU1507211A3/ru active
- 1985-08-14 KR KR1019850005863A patent/KR920002128B1/ko not_active IP Right Cessation
- 1985-08-14 CA CA000488662A patent/CA1255314A/fr not_active Expired
- 1985-08-14 UA UA3947161A patent/UA7140A1/uk unknown
- 1985-08-14 ES ES546152A patent/ES8607288A1/es not_active Expired
- 1985-08-15 NO NO853226A patent/NO163131C/no not_active IP Right Cessation
- 1985-08-15 HU HU853151A patent/HU195210B/hu unknown
-
1986
- 1986-12-02 US US06/937,193 patent/US4689333A/en not_active Expired - Lifetime
-
1991
- 1991-12-04 SG SG1032/91A patent/SG103291G/en unknown
-
1992
- 1992-01-16 HK HK47/92A patent/HK4792A/xx not_active IP Right Cessation
- 1992-06-19 MX MX9203043A patent/MX9203043A/es unknown
-
1993
- 1993-03-11 GE GEAP1993601A patent/GEP19960313B/en unknown
- 1993-06-29 NL NL930109C patent/NL930109I2/nl unknown
-
1994
- 1994-02-11 BG BG98459A patent/BG60415B2/bg unknown
-
1995
- 1995-03-31 NO NO1995002C patent/NO1995002I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK171340B1 (da) | Substituerede 2-((4-fluoralkoxypyrid-2-yl)metyltio eller metylsulfinyl)benzimidazoler, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende en sådan forbindelse | |
DK170819B1 (da) | Substituerede 2-[(3,4-dialkoxypyrid-2-yl)metyltio eller metylsulfinyl]benzimidazoler, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende en sådan forbindelse | |
US4555518A (en) | Fluoroalkoxy substituted benzimidazoles useful as gastric acid secretion inhibitors | |
US4727150A (en) | Pyridyl methylsulfinyl benzimidazole derivatives | |
CA1180017A (fr) | Phenoxypiridines soufrees antivirales | |
CA2405304C (fr) | Procede permettant d'obtenir des derives de [[(pyridil substitue)methyl]thio]benzimidazole | |
EP0262845A1 (fr) | Dérivés de l'azole à substituant hétérocyclique | |
EP0295603A1 (fr) | Dérivés de la benzimidazole et agents thérapeutiques contre l'ulcère les contenant | |
NO164472B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler. | |
US5312824A (en) | Certain 2-[(4-difluoromethoxy-2-pyridyl)-methylthio or methylsulfinyl-5-benzimidazoles useful for treating peptic ulcers | |
JPH0313234B2 (fr) | ||
NO170931B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-alkylbenzimidazolderivater | |
FR2491064A1 (fr) | Quinolones, leurs procedes de preparation et composition therapeutique les contenant | |
JPH0798825B2 (ja) | スルフエンアミド誘導体およびその製造法 | |
KR950014792B1 (ko) | 벤즈이미다졸 유도체 및 이의 제조방법 | |
JPS6216469A (ja) | 2−置換シクロヘプトイミダゾ−ル誘導体、抗潰瘍剤及びその製造方法 | |
JP2816974B2 (ja) | ベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤 | |
JP3163382B2 (ja) | ピリジン誘導体およびその製造法 | |
NO179004B (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater | |
KR0139260B1 (ko) | 고리화된 이미다졸을 가지는 벤즈이미다졸 유도체 | |
DK151802B (da) | Pyridylmetyltiobenzimidazoler eller salte deraf | |
LU86013A1 (fr) | Sulfoxydes et sulfones d'aminoalcool heterocycliques,leur preparation et leur utilisation ainsi que les compositions contenant ces derives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
CTFF | Application for supplementary protection certificate (spc) filed |
Free format text: CA 1997 00003, 970117 |
|
CTFF | Application for supplementary protection certificate (spc) filed |
Free format text: PRODUCT NAME: LANSOPRAZOL, CLARITHROMYCIN, METRONIDAZOL Spc suppl protection certif: CA 1997 0007 Filing date: 19970129 Free format text: CA 1997 00009, 970129 |
|
PUP | Patent expired | ||
CTFW | Supplementary protection certificate (spc) withdrawn, refused or deemed withdrawn |
Free format text: PRODUCT NAME: LANSOPRAZOL, AMOXICILLIN, METRONIDAZOL Spc suppl protection certif: CA 1997 00008 Free format text: PRODUCT NAME: LANSOPRAZOL, CLARITHROMYCIN, AMOXICILLIN Spc suppl protection certif: CA 1997 00009 |